RECRUITING

Evaluation of the Effects of Ketorolac Dose on Duration of Analgesia in Emergency Department (ED) Renal Colic Patients

Description

This is a prospective interventional study examining the effect of ketorolac at doses of 15mg versus 30 mg for duration of analgesia in emergency department patients with suspected renal colic.

Conditions

Renal ColicFlank PainEmergenciesAnalgesia
Talk to us

Related Conditions:

Renal ColicFlank PainEmergenciesAnalgesia

Study Overview

On this page

Study Details

Study overview

This is a prospective interventional study examining the effect of ketorolac at doses of 15mg versus 30 mg for duration of analgesia in emergency department patients with suspected renal colic.

Evaluation of the Effects of Ketorolac 15mg IV Versus 30mg IV on Duration of Analgesia in Patients Who Present to the Emergency Department With Renal Colic

Evaluation of the Effects of Ketorolac Dose on Duration of Analgesia in Emergency Department (ED) Renal Colic Patients

Condition
Renal Colic
Intervention / Treatment

-

Contacts and Locations

Hackensack

Hackensack Univarsity medical Center, Hackensack, New Jersey, United States, 07601

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Adult emergency department patients \< 65 years old
  • * One or more of the following common ED chief complaints associated with the suspected diagnosis of renal colic. These chief complaints include but are not limited to: flank pain, back pain, abdominal pain, left and/or right lower quadrant pain, and/or pelvic pain
  • * Pain score of 4 or greater on the 0-10 NRS
  • * Determination of treatment with IV ketorolac
  • * Allergy to ketorolac
  • * Pregnant patients
  • * Previously received analgesic medications within 4 hours prior to administration of ketorolac in our ED
  • * Known or stated history of renal insufficiency
  • * Body weight \< 50 kg
  • * Age greater than 65 years
  • * Patients that do no read/write Spanish or English

Ages Eligible for Study

18 Years to 65 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Hackensack Meridian Health,

Biren Bhatt, MD, PRINCIPAL_INVESTIGATOR, Hackensack Meridian Health

Study Record Dates

2026-02-28